These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25457108)

  • 1. [Antiphospholipids antibodies and hemodialysis: a frequent association linked to arteriovenous fistula thrombosis].
    Bataille S; Burtey S; Decourt A; Frère C; Henneuse A; Aillaud MF; Morange P; Bardin N; Duval A; Sallée M; Jourde-Chiche N; Gondouin B; Samson L; Cohen J; Berland Y; Brunet P
    Nephrol Ther; 2015 Feb; 11(1):27-33. PubMed ID: 25457108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis.
    Brunet P; Aillaud MF; San Marco M; Philip-Joet C; Dussol B; Bernard D; Juhan-Vague I; Berland Y
    Kidney Int; 1995 Sep; 48(3):794-800. PubMed ID: 7474666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
    Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid (aPL) antibodies in end-stage renal disease.
    Fabrizi F; Sangiorgio R; Pontoriero G; Corti M; Tentori F; Troina E; Locatelli F
    J Nephrol; 1999; 12(2):89-94. PubMed ID: 10378664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary antiphospholipid syndrome in a hemodialysis patient with recurrent thrombosis of arteriovenous fistulas.
    Gjorgjievski N; Dzekova-Vidimliski P
    J Bras Nefrol; 2019 Jul; 42(2):259-263. PubMed ID: 31419276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies and hemodialysis vascular access thrombosis.
    Harwood L; Wilson B
    Nephrol Nurs J; 2001 Jun; 28(3):346-7. PubMed ID: 12143457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arteriovenous fistula thrombosis in patients on regular hemodialysis: a report of 171 patients.
    Roozbeh J; Serati AR; Malekhoseini SA
    Arch Iran Med; 2006 Jan; 9(1):26-32. PubMed ID: 16649374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antiphospholipid antibodies in Syrian patients with thrombosis.
    Deeb A; Hamdoun S; Dababo K
    Iran J Immunol; 2009 Sep; 6(3):154-9. PubMed ID: 19801789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
    Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent hemodialysis graft thrombosis: association with antiphospholipid antibodies.
    Prieto LN; Suki WN
    Am J Kidney Dis; 1994 Apr; 23(4):587-90. PubMed ID: 8154497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
    Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
    Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein predicts vascular access thrombosis in hemodialysis patients.
    Chou CY; Kuo HL; Yung YF; Liu YL; Huang CC
    Blood Purif; 2006; 24(4):342-6. PubMed ID: 16601326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between antiphospholipid antibodies and arterial thrombosis in patients with rheumatoid arthritis.
    Kim KJ; Baek IW; Park KS; Kim WU; Cho CS
    Lupus; 2017 Jan; 26(1):88-94. PubMed ID: 27510601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
    Levine SR; Brey RL; Tilley BC; Thompson JL; Sacco RL; Sciacca RR; Murphy A; Lu Y; Costigan TM; Rhine C; Levin B; Triplett DA; Mohr JP;
    JAMA; 2004 Feb; 291(5):576-84. PubMed ID: 14762036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus.
    Tomás JF; Alberca I; Tabernero MD; Cordero M; Del Pino-Montes J; Vicente V
    J Rheumatol; 1998 Jan; 25(1):57-62. PubMed ID: 9458203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events.
    Ho KT; Ahn CW; Alarcón GS; Baethge BA; Tan FK; Roseman J; Bastian HM; Fessler BJ; McGwin G; Vilá LM; Calvo-Alén J; Reveille JD
    Rheumatology (Oxford); 2005 Oct; 44(10):1303-7. PubMed ID: 16030085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.
    Otomo K; Atsumi T; Amengual O; Fujieda Y; Kato M; Oku K; Horita T; Yasuda S; Koike T
    Arthritis Rheum; 2012 Feb; 64(2):504-12. PubMed ID: 21953404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombophilia and the risk for hemodialysis vascular access thrombosis.
    Knoll GA; Wells PS; Young D; Perkins SL; Pilkey RM; Clinch JJ; Rodger MA
    J Am Soc Nephrol; 2005 Apr; 16(4):1108-14. PubMed ID: 15728780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.
    Manns BJ; Burgess ED; Parsons HG; Schaefer JP; Hyndman ME; Scott-Douglas NW
    Kidney Int; 1999 Jan; 55(1):315-20. PubMed ID: 9893142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.